Minneapolis, MN, United States of America

Craig Bierle

This inventor holds 2 USPTO granted patents. Top assignee: Regents of the University of Minnesota. Active years: 2020-2022.


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020-2022

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Craig Bierle: Innovator in Brain Tumor Treatment

Introduction

Craig Bierle is a notable inventor based in Minneapolis, MN (US). He has made significant contributions to the field of medical research, particularly in the treatment of brain tumors. With a total of 2 patents, his work focuses on innovative methods that leverage the Zika virus for therapeutic purposes.

Latest Patents

Bierle's latest patents include groundbreaking methods and compositions for treating glioma and medulloblastoma brain tumors using the Zika virus. In one embodiment, the present invention outlines a method of treating these types of brain tumors through the application of the Zika virus in conjunction with a tumor vaccine. This innovative approach aims to provide new avenues for effective treatment options for patients suffering from these aggressive forms of cancer.

Career Highlights

Craig Bierle is affiliated with the Regents of the University of Minnesota, where he conducts his research and development. His work is characterized by a commitment to advancing medical science and improving patient outcomes through innovative solutions.

Collaborations

Some of his notable coworkers include Joseph Voth and Andrew Crane, who contribute to the collaborative efforts in research and development within the university setting.

Conclusion

Craig Bierle's contributions to the field of brain tumor treatment exemplify the impact of innovative thinking in medical research. His work continues to inspire advancements that may lead to better treatment options for patients in need.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…